The concept of general health checkups to identify disease at a stage at which early intervention could be effective has been promoted for nearly 100 years.1 Both patients and primary care physicians are interested in such examinations, which can include detailed history taking, physical examination, extensive laboratory testing, and imaging.2,3 However, there has been little evidence to support the benefits of such checkups, and the US Preventive Services Task Force recommends a limited range of age-, sex-, and risk-specific examinations and tests.4 The goal of this review was to estimate the effect of health checkups on morbidity and mortality based on primary care–or community-based randomized controlled trials (RCTs) with long-term follow-up in adults.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
As the authors of commentaries on the same Cochrane review on which Prochazka and Caverly have commented, we were surprised that they failed to discuss the Million Hearts Initiative and the new annual wellness visit for Medicare beneficiaries. Although the available Million Hearts Initiative policies are vague on the frequency of checks for the presence of cardiovascular disease (CVD) risk factors, this is not the case with the Medicare policy. Are these not general health checks? Prochazka and Caverly acknowledge the advent of new, cheap and individually effective interventions to reduce risk factors (such as generic statins), and the lack of recent research available to the review, and yet state that the "belief in the value of general health checks persists despite the accumulating evidence". What accumulating evidence? The advent of new interventions and the concept of reducing global CVD risk should have led to more recent trials of CVD risk factor screening programmes by government agencies, but unfortunately it did not, and that window of opportunity is now closing. Despite the lack of modern clinical trial evidence, the English Government has embarked on a programme, NHS Health Checks, to screen all 40-74 year olds for CVD risk factors, based on expert advice, local experiments, cost-effectiveness modelling, and strong and universal primary health care services. While we can deplore the historic hiatus in clinical trials, we suggest that the time to call for more of them has passed. Could patients with high CVD risk be denied statin treatment in a trial? We need to evaluate the impact of what is happening before our eyes, whether policy-driven or not.
1. Frieden TR, Berwick DM. The “Million Hearts” Initiative — Preventing Heart Attacks and Strokes. New England Journal of Medicine 2011;365(13):e27.
2. Cholesterol Treatment Trialists C. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. The Lancet 2012;380(9841):581-90.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.